Meta-analysis of trials comparing antidepressants with active placebos

British Journal of Psychiatry

Volumn 172, Issue MAR., 1998, Pages 227-234

  Moncrieff, Joanna ^a   Wessely, Simon ^a   Hardy, Rebecca ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; DATA ANALYSIS; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; QUALITY CONTROL; RATING SCALE;

EID: 0031891682     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.172.3.227     Document Type: Article

References (24)

1. Abramson, J. H. (1991) Meta-analysis: a review of pros and cons. Public Health Reviews, 18, 1-47.
2. Daneman, E. A. (1961) Imipramine in office management of depressive reactions. Diseases of the Nervous System, 22, 213-217.
3. Engelhardt, D. M., Margolis, R. A., Rudorfer, L., et al (1969) Physician bias and the double-blind. Archives of General Psychiatry, 20, 315-320.
4. Friedman, A. S. (1975) Interaction of drug therapy with marital therapy in depressive patients. Archives of General Psychiatry, 32, 619-637.
5. _, Granick, S., Cohen, H. W., et al (1966) Imipramine (tofranil) vs. placebo in hospitalised psychotic depressives. Journal of Psychiatric Research, 4, 13-36.
6. Gillin, J. C., Laurellio, J., Kelsoe, J. R., et al (1995) No antidepressant effect of biperiden compared with placebo in depression: A double-blind 6-week clinical trial. Psychiatric Research, 58, 99-105.
7. Greenberg, R. P., Bornstein, R. F., Greenberg, M. D., et al (1992) A meta-analysis of antidepressant outcome under "blinder" conditions. Journal of Consulting and Clinical Psychology, 60, 664-669.
8. _ & Fisher, S. (1994) Suspended judgement. Seeing through the double-masked design: a commentary. Controlled Clinical Trials, 15, 244-246.
9. Hedges, L. V. & Olkin, I. (1985) Statistical Methods for Meta-Analysis. San Diego, CA: Academic Press.
10. Hollister, L. E., Overall, J. E., Johnson, M., et al (1963) Evaluation of desipramine in depressive states. Journal of New Drugs, 3, 161-166.
11. _, _, _, et al (1964) Controlled comparison of imipramine, amitriptyline and placebo in hospitalised depressed patients. Journal of Nervous and Mental Disease, 139, 370-375.
12. Hussain, Z. (1970) Drugs in depressive illness. British Medical Journal, i, 482.
13. Kasper, S., Moises, H-W. & Beckmann, H. (1981) The anticholinergic biperiden in depressive disorders. Pharmacopsychiatry, 14, 195-198.
14. Medical Research Council (1965) Clinical trial of the treatment of depressive illness. British Medical Journal, i, 881-886.
15. Murphy, G. E., Simons, A. D., Wetzel, R. D., et al (1984) Cognitive therapy and pharmacotherapy. Archives of General Psychiatry, 41, 33-41.
16. Quality Assurance Project (1983) A treatment outline for depressive disorders. Australian and New Zealand Journal of Psychiatry, 17, 129-146.
17. Rush, A. J., Beck, A. T., Kovacs, M., et al (1977) Comparative effects of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients. Cognitive Research and Therapy, 1, 17-37.
18. Smith, M. C., Glass, G. V. & Miller, T. I. (1980) Reviews of research on the effects of drug therapy on psychological disorders. In The Benefits of Psychotherapy (eds M. C. Smith, G. V. Glass & T. I. Miller), pp. 127-261. Baltimore, MD: Johns Hopkins University Press.
19. Steinbrueck, S. M., Maxwell, S. E. & Howard, G. S. (1983) A meta-analysis of psychotherapy and drug therapy in the treatment of unipolar depression with adults. Journal of Consulting and Clinical Psychology, 51, 856-863.
20. Toneatto, T. & Sellers, E. M. (1992) Perception of whether drug or placebo has been administered is a determinant of drinking reduction. In Novel Pharmacological Interventions for Alcoholism (eds E. M. Sellers & C. A. Naranjo). Berlin: Springer Verlag.
21. Uhlenthuth, E. H. & Park, L. C. (1963) The influence of medication (imipramine) and doctor in relieving depressed psychoneurotic outpatients. Journal of Psychiatric Research, 2, 101-122.
22. Weintraub, W. & Aronson, H. (1963) Clinical judgement in psychopharmacological research. Journal of Neuropsychiatry, 5, 65-70.
23. White, K., Kando, J., Park, T., et al (1992) Side effects and the "blindability" of clinical drug trials. American Journal of Psychiatry, 149, 1730-1761.
24. Wilson, I. C., Vernon, J. T., Guin, T., et al (1963) A controlled study of treatments of depression. Journal of Neuropsychiatry, 4, 331-337.